FI120352B - Menetelmä ihmisen koolonin epiteelisolujen immortalisoimiseksi, ihmisen koolonin epiteelisolujen viljelemiseen ja immortalisoimiseen sopiva seerumia sisältämätön viljelyalusta, ihmisen koolonin immortalisoitu epiteelisolulinja, menetelmä suolikanavan.... - Google Patents
Menetelmä ihmisen koolonin epiteelisolujen immortalisoimiseksi, ihmisen koolonin epiteelisolujen viljelemiseen ja immortalisoimiseen sopiva seerumia sisältämätön viljelyalusta, ihmisen koolonin immortalisoitu epiteelisolulinja, menetelmä suolikanavan.... Download PDFInfo
- Publication number
- FI120352B FI120352B FI971628A FI971628A FI120352B FI 120352 B FI120352 B FI 120352B FI 971628 A FI971628 A FI 971628A FI 971628 A FI971628 A FI 971628A FI 120352 B FI120352 B FI 120352B
- Authority
- FI
- Finland
- Prior art keywords
- cells
- epithelial cells
- cell line
- human colon
- colon epithelial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0679—Cells of the gastro-intestinal tract
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/395—Thyroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201064A EP0802257B1 (de) | 1996-04-19 | 1996-04-19 | Menschliche immortalisierte Colon-Epithelialzellen |
EP96201064 | 1996-04-19 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI971628A0 FI971628A0 (fi) | 1997-04-17 |
FI971628A FI971628A (fi) | 1997-10-20 |
FI120352B true FI120352B (fi) | 2009-09-30 |
Family
ID=8223895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI971628A FI120352B (fi) | 1996-04-19 | 1997-04-17 | Menetelmä ihmisen koolonin epiteelisolujen immortalisoimiseksi, ihmisen koolonin epiteelisolujen viljelemiseen ja immortalisoimiseen sopiva seerumia sisältämätön viljelyalusta, ihmisen koolonin immortalisoitu epiteelisolulinja, menetelmä suolikanavan.... |
Country Status (14)
Country | Link |
---|---|
US (3) | US6194203B1 (de) |
EP (1) | EP0802257B1 (de) |
JP (1) | JP3931212B2 (de) |
AT (1) | ATE222598T1 (de) |
AU (1) | AU733913B2 (de) |
CA (1) | CA2202923C (de) |
DE (1) | DE69623109T2 (de) |
DK (1) | DK0802257T3 (de) |
ES (1) | ES2180689T3 (de) |
FI (1) | FI120352B (de) |
NO (1) | NO319494B1 (de) |
NZ (1) | NZ314614A (de) |
PT (1) | PT802257E (de) |
RU (1) | RU2220201C2 (de) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2180689T3 (es) * | 1996-04-19 | 2003-02-16 | Nestle Sa | Linea inmortalizada de celulas epiteliales del colon humano. |
ATE347587T1 (de) | 1996-12-24 | 2006-12-15 | Nestle Sa | Immortalisierte menschliche epithelzell-linie aus kornea |
US5960073A (en) * | 1997-04-03 | 1999-09-28 | Genesys Telecommunications Laboratories , Inc. | Method and apparatus for providing an interactive home agent with access to call center functionality and resources |
DE19755023C2 (de) * | 1997-12-11 | 2000-03-09 | Celanese Chem Europe Gmbh | Katalysator und Verfahren zur Herstellung von Vinylacetat |
DK1048725T3 (da) * | 1999-04-27 | 2005-08-22 | Transgene Sa | Fremgangsmåde til fremstilling af pattedyrcellelinjer |
EP1048724A1 (de) * | 1999-04-27 | 2000-11-02 | Transgene S.A. | Humane Myoblastzellinien und deren Anwendungen |
US6429013B1 (en) * | 1999-08-19 | 2002-08-06 | Artecel Science, Inc. | Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
US7078232B2 (en) * | 1999-08-19 | 2006-07-18 | Artecel, Inc. | Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof |
US6416999B1 (en) | 2000-04-07 | 2002-07-09 | Raven Biotechnologies, Inc. | Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof |
US6900056B2 (en) * | 2001-02-15 | 2005-05-31 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
US20030215941A1 (en) * | 2002-03-12 | 2003-11-20 | Stewart Campbell | Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound |
GB0212405D0 (en) * | 2002-05-29 | 2002-07-10 | Insignion Holdings Ltd | Composition and its therapeutic use |
US7115563B2 (en) * | 2002-05-29 | 2006-10-03 | Insignion Holding Limited | Composition and its therapeutic use |
ATE447953T1 (de) * | 2004-07-19 | 2009-11-15 | Inst Rech Developpement Ird | Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis |
US8273553B2 (en) * | 2004-11-02 | 2012-09-25 | Ares Trading S.A. | Production of growth hormone in serum-free cell culture medium for mammalian cells |
ZA200702434B (en) | 2004-11-02 | 2008-08-27 | Ares Trading Sa | Serum-free cell culture medium for mammalian cells |
EP2390263A1 (de) | 2005-08-26 | 2011-11-30 | Ares Trading S.A. | Verfahren zur Herstellung von glycosyliertem Interferon beta |
MY185872A (en) | 2006-09-13 | 2021-06-14 | Abbvie Inc | Cell culture improvements |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
TW201028433A (en) | 2008-10-20 | 2010-08-01 | Abbott Lab | Viral inactivation during purification of antibodies |
WO2010141039A1 (en) | 2008-10-20 | 2010-12-09 | Abbott Laboratories | Isolation and purification of antibodies using protein a affinity chromatography |
EP2702077A2 (de) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Verfahren zur steuerung des galactosylierungsprofil von rekombinant exprimierten proteinen |
GB2497249B (en) * | 2011-07-12 | 2016-12-28 | Foodchek Systems Inc | Culture medium,method for culturing salmonella and e.coli and method for detecting salmonella and e.coli |
US9150645B2 (en) | 2012-04-20 | 2015-10-06 | Abbvie, Inc. | Cell culture methods to reduce acidic species |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
US9206390B2 (en) | 2012-09-02 | 2015-12-08 | Abbvie, Inc. | Methods to control protein heterogeneity |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
EP2767273A1 (de) | 2013-02-15 | 2014-08-20 | Universitätsklinikum Erlangen | Todassoziierte Proteinkinasen, Hemmer und Aktivatoren für die Verwendung in pharmazeutischen Zusammensetzungen und vorhersagbare Medizin |
WO2014143205A1 (en) | 2013-03-12 | 2014-09-18 | Abbvie Inc. | Human antibodies that bind human tnf-alpha and methods of preparing the same |
US9499614B2 (en) | 2013-03-14 | 2016-11-22 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
US8921526B2 (en) | 2013-03-14 | 2014-12-30 | Abbvie, Inc. | Mutated anti-TNFα antibodies and methods of their use |
US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
WO2015073884A2 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
EP3352586A4 (de) | 2015-09-21 | 2019-05-15 | The Board Of Trustees Of The Leland Stanford Junior University | Ernährungsbehandlung bei krebserkrankungen |
US11060061B2 (en) * | 2017-08-09 | 2021-07-13 | Mandom Corporation | Immortalized sweat gland myoepithelial cell |
EP3723772A4 (de) | 2017-12-11 | 2021-09-08 | Filtricine, Inc. | Zusammensetzungen, verfahren, kits und systeme zur krebsbehandlung und stoffwechselinterventionstherapie |
CN111172114B (zh) * | 2019-12-10 | 2021-11-30 | 上海中医药大学附属岳阳中西医结合医院 | 一种人源化肠癌前病变永生化上皮细胞系、构建方法及其应用 |
CN114891722A (zh) * | 2022-05-13 | 2022-08-12 | 广东省农业科学院动物卫生研究所 | 禽肠道上皮细胞及其制备方法和应用 |
CN116083342A (zh) * | 2023-01-16 | 2023-05-09 | 细新(上海)医疗科技有限公司 | 一种原代上皮细胞的培养体系和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4229531A (en) * | 1978-12-29 | 1980-10-21 | Monsanto Company | Production of tumor angiogenesis factor by cell culture |
DE3711699A1 (de) * | 1987-04-07 | 1988-11-10 | Fraunhofer Ges Forschung | Medium zur kultivierung und proliferation von epithelialen zelltypen |
US4885238A (en) * | 1987-10-30 | 1989-12-05 | The United States Of America As Represented By The Department Of Health And Human Services | Immortalized human bronchial epitherial mesothelial cell lines |
WO1989005862A1 (en) * | 1987-12-09 | 1989-06-29 | Invitron Corporation | Human cell life extension |
US5093259A (en) * | 1988-07-07 | 1992-03-03 | Oak Ridge Associated Universities, Inc. | Continuous cell-line tamarin adenocarcinoma of the colon |
US5665589A (en) * | 1988-12-14 | 1997-09-09 | The United States Of America As Represented By The Department Of Health And Human Services | Human liver epithelial cell lines |
US5529920A (en) * | 1988-12-14 | 1996-06-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Human liver epithelial cell line and culture media therefor |
US5376542A (en) | 1992-04-27 | 1994-12-27 | Georgetown University | Method for producing immortalized cell lines using human papilluma virus genes |
ATE172245T1 (de) | 1992-07-06 | 1998-10-15 | Nestle Sa | Milchbakterien |
US5462870A (en) * | 1993-04-23 | 1995-10-31 | Wayne State University | Human diploid salivary gland epithelial cell lines |
US5672498A (en) * | 1993-12-28 | 1997-09-30 | The Gillete Company | Human corneal epithelial cell lines with extended lifespan |
US5610043A (en) * | 1994-04-28 | 1997-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus |
ES2180689T3 (es) * | 1996-04-19 | 2003-02-16 | Nestle Sa | Linea inmortalizada de celulas epiteliales del colon humano. |
-
1996
- 1996-04-19 ES ES96201064T patent/ES2180689T3/es not_active Expired - Lifetime
- 1996-04-19 PT PT96201064T patent/PT802257E/pt unknown
- 1996-04-19 AT AT96201064T patent/ATE222598T1/de active
- 1996-04-19 DE DE69623109T patent/DE69623109T2/de not_active Expired - Lifetime
- 1996-04-19 EP EP96201064A patent/EP0802257B1/de not_active Expired - Lifetime
- 1996-04-19 DK DK96201064T patent/DK0802257T3/da active
-
1997
- 1997-04-16 NZ NZ314614A patent/NZ314614A/en not_active IP Right Cessation
- 1997-04-16 RU RU97106170/13A patent/RU2220201C2/ru not_active IP Right Cessation
- 1997-04-16 CA CA002202923A patent/CA2202923C/en not_active Expired - Fee Related
- 1997-04-17 AU AU18933/97A patent/AU733913B2/en not_active Ceased
- 1997-04-17 US US08/839,271 patent/US6194203B1/en not_active Expired - Lifetime
- 1997-04-17 FI FI971628A patent/FI120352B/fi not_active IP Right Cessation
- 1997-04-17 NO NO19971757A patent/NO319494B1/no not_active IP Right Cessation
- 1997-04-18 JP JP10217297A patent/JP3931212B2/ja not_active Expired - Fee Related
-
2000
- 2000-06-14 US US09/593,135 patent/US6399381B1/en not_active Expired - Lifetime
- 2000-06-14 US US09/593,134 patent/US6395542B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU1893397A (en) | 1997-10-23 |
NZ314614A (en) | 1999-04-29 |
DK0802257T3 (da) | 2002-10-28 |
CA2202923C (en) | 2008-06-10 |
EP0802257B1 (de) | 2002-08-21 |
JPH1028580A (ja) | 1998-02-03 |
CA2202923A1 (en) | 1997-10-19 |
NO319494B1 (no) | 2005-08-22 |
FI971628A0 (fi) | 1997-04-17 |
FI971628A (fi) | 1997-10-20 |
DE69623109D1 (de) | 2002-09-26 |
NO971757D0 (no) | 1997-04-17 |
RU2220201C2 (ru) | 2003-12-27 |
ES2180689T3 (es) | 2003-02-16 |
EP0802257A1 (de) | 1997-10-22 |
US6194203B1 (en) | 2001-02-27 |
NO971757L (no) | 1997-10-20 |
JP3931212B2 (ja) | 2007-06-13 |
ATE222598T1 (de) | 2002-09-15 |
US6395542B1 (en) | 2002-05-28 |
PT802257E (pt) | 2003-01-31 |
US6399381B1 (en) | 2002-06-04 |
DE69623109T2 (de) | 2002-12-12 |
AU733913B2 (en) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI120352B (fi) | Menetelmä ihmisen koolonin epiteelisolujen immortalisoimiseksi, ihmisen koolonin epiteelisolujen viljelemiseen ja immortalisoimiseen sopiva seerumia sisältämätön viljelyalusta, ihmisen koolonin immortalisoitu epiteelisolulinja, menetelmä suolikanavan.... | |
US11530385B2 (en) | Hormone responsive tissue culture system and uses thereof | |
US20050260748A1 (en) | Adult stem cells and uses thereof | |
US9951315B2 (en) | Immortalization of epithelial cells and methods of use | |
US8715954B2 (en) | Method of producing C3A serum-free clonal cell line | |
CN1439049A (zh) | 衍生自多能干细胞的肝细胞谱系细胞 | |
US7294509B2 (en) | Pre-adipose cell lines | |
CN1205737A (zh) | 改良无限增殖化人类皮肤细胞系和用于其生产的新型无血清培育基 | |
ES2229219T3 (es) | Lineas celulares humanas inmortalizadas que contienen genes del citocromo p450 exogenos. | |
US20060154235A1 (en) | Human hepatocyte-like cells and uses thereof | |
EP1704227A1 (de) | Immortalisierte hepatozyten | |
EP0851028B1 (de) | Immortalisierte menschliche Epithelzell-Linie aus Kornea | |
EP0929661A1 (de) | Neuartiges verfahren der kultivierung menschlicher epithelzellenzur identifizierung von therapeutika und diagnostika gegen krebs | |
Stacey et al. | Immortalisation of primary cells | |
Yoshizato | Growth potential of adult hepatocytes in mammals: Highly replicative small hepatocytes with liver progenitor‐like traits | |
Brash et al. | Overview of human cells in genetic research: Altered phenotypes in human cells caused by transferred genes | |
US8133729B2 (en) | Biomimetic urothelium | |
Grisham et al. | Clonal analysis of neoplastic transformation in cultured diploid rat liver epithelial cells | |
WO2002064017A2 (en) | Immortalized human prostatic cancer cell lines | |
WO2002064018A2 (en) | Immortalized human familial prostatic cancer cell lines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 120352 Country of ref document: FI |
|
MM | Patent lapsed |